KR20130122979A - 카제인으로부터 유도된 펩티드로 구성된 약학 조성물 및 이를 이용하는 방법 - Google Patents

카제인으로부터 유도된 펩티드로 구성된 약학 조성물 및 이를 이용하는 방법 Download PDF

Info

Publication number
KR20130122979A
KR20130122979A KR1020137025206A KR20137025206A KR20130122979A KR 20130122979 A KR20130122979 A KR 20130122979A KR 1020137025206 A KR1020137025206 A KR 1020137025206A KR 20137025206 A KR20137025206 A KR 20137025206A KR 20130122979 A KR20130122979 A KR 20130122979A
Authority
KR
South Korea
Prior art keywords
casein
milk
peptide
treatment
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020137025206A
Other languages
English (en)
Korean (ko)
Inventor
조세 마리오 이스코비치
니심 실라니코브
자비르 이스코비치
Original Assignee
밀레우티스 엘티디.
스테이트 오브 이스라엘, 미니스트리 오브 애그리컬쳐 앤드 루럴 디벨롭먼트, 애그리컬츄럴 리서치 오가니제이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 밀레우티스 엘티디., 스테이트 오브 이스라엘, 미니스트리 오브 애그리컬쳐 앤드 루럴 디벨롭먼트, 애그리컬츄럴 리서치 오가니제이션 filed Critical 밀레우티스 엘티디.
Publication of KR20130122979A publication Critical patent/KR20130122979A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
KR1020137025206A 2005-05-02 2006-05-02 카제인으로부터 유도된 펩티드로 구성된 약학 조성물 및 이를 이용하는 방법 Ceased KR20130122979A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US67629205P 2005-05-02 2005-05-02
US60/676,292 2005-05-02
US68869705P 2005-06-09 2005-06-09
US60/688,697 2005-06-09
PCT/IL2006/000524 WO2006117784A2 (en) 2005-05-02 2006-05-02 Pharmaceutical compositions comprising casein derived peptides and methods of use thereof

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020077028185A Division KR101340676B1 (ko) 2005-05-02 2006-05-02 카제인으로부터 유도된 펩티드로 구성된 약학 조성물 및이를 이용하는 방법

Publications (1)

Publication Number Publication Date
KR20130122979A true KR20130122979A (ko) 2013-11-11

Family

ID=37308387

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020137025206A Ceased KR20130122979A (ko) 2005-05-02 2006-05-02 카제인으로부터 유도된 펩티드로 구성된 약학 조성물 및 이를 이용하는 방법
KR1020077028185A Expired - Lifetime KR101340676B1 (ko) 2005-05-02 2006-05-02 카제인으로부터 유도된 펩티드로 구성된 약학 조성물 및이를 이용하는 방법

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020077028185A Expired - Lifetime KR101340676B1 (ko) 2005-05-02 2006-05-02 카제인으로부터 유도된 펩티드로 구성된 약학 조성물 및이를 이용하는 방법

Country Status (18)

Country Link
US (2) US7968513B2 (enExample)
EP (1) EP1890720B1 (enExample)
JP (1) JP5247429B2 (enExample)
KR (2) KR20130122979A (enExample)
CN (1) CN106421749A (enExample)
AR (1) AR059462A1 (enExample)
AU (1) AU2006242842B2 (enExample)
BR (1) BRPI0611301A2 (enExample)
CA (1) CA2607155C (enExample)
CL (1) CL2011000039A1 (enExample)
EA (1) EA016039B1 (enExample)
ES (1) ES2400511T3 (enExample)
IN (1) IN2014DN10391A (enExample)
MX (1) MX2007013866A (enExample)
NZ (1) NZ563936A (enExample)
PL (1) PL1890720T3 (enExample)
UY (1) UY29515A1 (enExample)
WO (1) WO2006117784A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY29515A1 (es) * 2005-05-02 2007-11-30 Mileutis Ltd Composiciones farmaceuticas que constan de peptidos derivados de la caseina y métodos del uso de los mismos
JP5507555B2 (ja) * 2008-06-30 2014-05-28 チョ−エー・ファーム・カンパニー・リミテッド 豚のαＳ１カゼイン遺伝子、そのプロモーター、及びその用途
US8133916B1 (en) 2009-03-10 2012-03-13 Amelgo, LLC Control of milk production and mammary involution
US20110017323A1 (en) * 2009-07-22 2011-01-27 Ewa Herbst Method and apparatus for inline testing
CA2797658C (en) * 2010-04-21 2021-06-08 Mileutis Ltd. Casein peptide for use in the treatment of uterine infections
FR2971423B1 (fr) * 2011-02-15 2014-01-10 Ceva Sante Animale Composition veterinaire antiprolactinique destinee aux ruminants
ES2759980T3 (es) * 2012-03-19 2020-05-12 Mileutis Ltd Péptidos para el manejo de la lactación
EP2810695A1 (en) * 2013-06-06 2014-12-10 Ceva Sante Animale Compositions and Method for controlling infections in non-human mammals using acute phase proteins
NZ753824A (en) * 2016-11-09 2022-08-26 Charles Sturt Univ Livestock supplement and use thereof
AU2017376402B2 (en) * 2016-12-13 2021-10-28 Dsm Ip Assets B.V. PUFA salt formulations (I)
CN108017709B (zh) * 2017-12-12 2020-04-10 浙江辉肽生命健康科技有限公司 一种生物活性多肽kepmigvnqela及其制备方法和应用
US20230106635A1 (en) * 2020-02-19 2023-04-06 Perfect Day, Inc. Hypoallergenic recombinant milk proteins and compositions comprising the same
EP4329790A1 (en) * 2021-04-28 2024-03-06 Mileutis Ltd. Compositions and methods for modulating mammary disorders and conditions
CN120379680A (zh) * 2022-11-17 2025-07-25 米勒尤迪斯公司 用于调节乳腺病症和病状的组合物和方法
CN121358342A (zh) * 2023-05-16 2026-01-16 米勒尤迪斯公司 提升的乳质
WO2026159713A1 (en) * 2025-01-23 2026-07-30 Mileutis Ltd. A method of increasing milk production

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3764670A (en) * 1970-10-28 1973-10-09 Ministry Of Agriculture Polypeptidic anti-biotic substances derived from casein
FR2474829B1 (fr) * 1980-02-01 1983-09-09 Agronomique Inst Nat Rech Procede de traitement d'une matiere a base de caseine contenant des phosphocaseinates de cations monovalents ou leurs derives, produits obtenus et applications
US5405756A (en) * 1982-03-30 1995-04-11 Meiji Seika Kaisha, Ltd. Transparent acid drink containing acid-soluble casein phosphopeptide
US5015628A (en) * 1986-06-12 1991-05-14 The University Of Melbourne Anticariogenic phosphopeptides
ES2149771T3 (es) * 1991-04-19 2000-11-16 Univ Melbourne Produccion de fosfopeptidos a partir de la caseina.
US5227154A (en) * 1991-08-22 1993-07-13 The University Of Melbourne Phosphopeptides for the treatment of dental calculus
KR0140248B1 (ko) * 1995-03-23 1998-06-15 한상기 신규한 카제인 포스포펩티드, 그것을 포함하는 카제인 및 그 제조방법
AUPO566297A0 (en) * 1997-03-13 1997-04-10 University Of Melbourne, The Calcium phosphopeptide complexes
AUPP494798A0 (en) * 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
AU775999B2 (en) 1999-08-24 2004-08-19 Meiji Seika Pharma Co., Ltd. Growth promoting compositions for mammals and method of promoting the growth of mammals by using the same
US6391849B1 (en) * 1999-11-19 2002-05-21 Agricultural Research Organization, The Volcani Center Method and pharmaceutical composition for disrupting lactation in a mammary gland and for treating and preventing mastitis
IL134830A0 (en) * 2000-03-01 2001-05-20 Chay 13 Medical Res Group N V Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them
US7666996B2 (en) * 2000-03-01 2010-02-23 Peptera Pharmaceuticals Ltd Casein derived peptides and uses thereof
JPWO2002072629A1 (ja) * 2001-03-09 2004-07-02 明治製菓株式会社 免疫増強剤
KR20070007128A (ko) 2004-03-01 2007-01-12 펩테라 파마슈티컬스 엘티디. 카제인 파생 펩타이드들과 그의 치료적 사용들
UY29515A1 (es) * 2005-05-02 2007-11-30 Mileutis Ltd Composiciones farmaceuticas que constan de peptidos derivados de la caseina y métodos del uso de los mismos

Also Published As

Publication number Publication date
JP5247429B2 (ja) 2013-07-24
EA200702401A1 (ru) 2008-08-29
WO2006117784A2 (en) 2006-11-09
IN2014DN10391A (enExample) 2015-08-14
BRPI0611301A2 (pt) 2010-08-31
US7968513B2 (en) 2011-06-28
EA016039B1 (ru) 2012-01-30
JP2008540399A (ja) 2008-11-20
CA2607155C (en) 2016-09-13
NZ563936A (en) 2010-03-26
CL2011000039A1 (es) 2011-06-10
CA2607155A1 (en) 2006-11-09
EP1890720A2 (en) 2008-02-27
WO2006117784A3 (en) 2009-05-22
US20090069218A1 (en) 2009-03-12
US8338363B2 (en) 2012-12-25
ES2400511T3 (es) 2013-04-10
US20110212886A1 (en) 2011-09-01
KR20080012933A (ko) 2008-02-12
EP1890720B1 (en) 2013-01-09
KR101340676B1 (ko) 2013-12-18
CN106421749A (zh) 2017-02-22
AU2006242842A1 (en) 2006-11-09
PL1890720T3 (pl) 2013-06-28
EP1890720A4 (en) 2010-05-26
AR059462A1 (es) 2008-04-09
AU2006242842B2 (en) 2011-12-08
UY29515A1 (es) 2007-11-30
MX2007013866A (es) 2008-04-07

Similar Documents

Publication Publication Date Title
US8338363B2 (en) Pharmaceutical compositions comprising casein derived peptides and methods of use thereof
US9861678B2 (en) Casein peptide for use in the treatment of uterine infections
US20240207352A1 (en) Compositions and methods for modulating mammary disorders and conditions
AU2013236975B2 (en) Peptides for management of lactation
CN101247721B (zh) 包括酪蛋白衍生肽的药物组合物及其使用方法
AU2012200889B2 (en) Pharmaceutical compositions comprising casein derived peptides and methods of use thereof
HK1120368A (en) Pharmaceutical compositions comprising casein derived peptides and methods of use thereof
IL222487A (en) Casein-derived peptides and methods for using them to increase milk yield
IL222486A (en) Casein-derived peptides and methods for using them to enhance milk cleanliness
IL187120A (en) Casein-derived peptides and methods for their use in the herd's interface with milk
AU2015258315A1 (en) Casein peptide for use in the treatment of uterine infections
JP2025537820A (ja) 乳房の障害および状態を調節するための組成物および方法

Legal Events

Date Code Title Description
A107 Divisional application of patent
A201 Request for examination
PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A18-div-PA0104

St.27 status event code: A-0-1-A10-A16-div-PA0104

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

R18 Changes to party contact information recorded

Free format text: ST27 STATUS EVENT CODE: A-3-3-R10-R18-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000